Clinical Trials Directory

Trials / Unknown

UnknownNCT04953936

β-hydroxy-β-methylbutyrate-enriched Nutritional Supplements for Obesity Adults

β-hydroxy-β-methylbutyrate-enriched Nutritional Supplements for Obesity Adults During Weight Loss: a Randomized Double-blind Placebo-controlled Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the effectiveness and safety of HMB-enriched nutritional supplements for improving muscle mass and muscle function in Chinese adults with obesity during the weight loss process using calorie restriction.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHMB-enriched Nutritional SupplementsThe participants will receive oral HMB-enriched nutritional supplements (65 g, once daily), which include soybean isolate protein, flaxseed oil powder, yam powder, whey protein, oligomeric isomaltose powder, cocoa powder, medium-chain fatty acid powder, calcium beta-hydroxy-beta-methylbutyrate, sunflower seed oil powder, L-glutamine, wheat germ powder, membrane isolated casein, wheat oligopeptide, konjac flour, vitamin E, vitamin D, stevioside, edible flavors.
DIETARY_SUPPLEMENTPlaceboPlacebo (maltodextrin 65 g once daily) with the same package as the intervention.
BEHAVIORALCaloric Restrition DietCaloric restriction diet with individualized nutritional guidance from professional dietitians by video regarding caloric restriction strategies

Timeline

Start date
2021-09-20
Primary completion
2021-10-31
Completion
2021-12-31
First posted
2021-07-08
Last updated
2021-09-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04953936. Inclusion in this directory is not an endorsement.